human k562 erythroleukemia cells were selected in sequential steps for resistance to daunorubicin ( k562/iii ) and found to be cross-resistant to a number of drugs , including vincristine , dactinomycin , doxorubicin , etoposide , and teniposide .
C0011015
daunorubicin
C0013089
doxorubicin